rs10250905
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_016616.5(NME8):āc.622T>Cā(p.Cys208Arg) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.74 in 1,607,556 control chromosomes in the GnomAD database, including 441,764 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_016616.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NME8 | ENST00000199447.9 | c.622T>C | p.Cys208Arg | missense_variant, splice_region_variant | 11/18 | 1 | NM_016616.5 | ENSP00000199447.4 | ||
NME8 | ENST00000440017.5 | c.622T>C | p.Cys208Arg | missense_variant, splice_region_variant | 10/16 | 1 | ENSP00000397063.1 | |||
ENSG00000290149 | ENST00000476620.1 | c.-38+10357T>C | intron_variant | 4 | ENSP00000425858.1 | |||||
NME8 | ENST00000426106.1 | n.105+10357T>C | intron_variant | 5 | ENSP00000408841.1 |
Frequencies
GnomAD3 genomes AF: 0.771 AC: 117148AN: 151884Hom.: 45487 Cov.: 31
GnomAD3 exomes AF: 0.732 AC: 183376AN: 250628Hom.: 67672 AF XY: 0.733 AC XY: 99287AN XY: 135504
GnomAD4 exome AF: 0.736 AC: 1071706AN: 1455554Hom.: 396227 Cov.: 32 AF XY: 0.737 AC XY: 533756AN XY: 724446
GnomAD4 genome AF: 0.771 AC: 117255AN: 152002Hom.: 45537 Cov.: 31 AF XY: 0.768 AC XY: 57048AN XY: 74308
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 11, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Primary ciliary dyskinesia 6 Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Primary ciliary dyskinesia Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2014 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at